HELLP	B:C0162739
Syndrome	I:C0162739
.	O

The	O
hemolysis	B:C2903579
,	I:C2903579
elevated	I:C2903579
liver	I:C2903579
enzymes	I:C2903579
,	I:C2903579
and	I:C2903579
low	I:C2903579
platelet	I:C2903579
count	I:C2903579
(	I:C2903579
HELLP	I:C2903579
)	I:C2903579
syndrome	I:C2903579
is	O
frequently	O
observed	O
in	O
mothers	O
whose	O
offspring	O
have	O
long	B:C0522095
-	I:C0522095
chain	I:C0522095
fatty	I:C0522095
acid	I:C0522095
oxidation	B:C0030011
defects	O
.	O

We	O
previously	O
found	O
that	O
fatty	B:C1158366
acid	I:C1158366
oxidation	I:C1158366
is	O
compromised	O
not	O
only	O
in	O
these	O
inborn	B:C0025521
errors	I:C0025521
of	I:C0025521
metabolism	I:C0025521
but	O
also	O
in	O
human	B:C3179121
umbilical	I:C3179121
vein	I:C3179121
endothelial	I:C3179121
cells	I:C3179121
(	O
human	B:C3179121
umbilical	I:C3179121
vein	I:C3179121
endothelial	I:C3179121
cells	I:C3179121
)	O
from	O
all	O
pregnancies	B:C0032962
complicated	I:C0032962
by	O
the	O
HELLP	B:C0162739
syndrome	I:C0162739
.	O

Sirtuins	B:C1136177
are	O
oxidized	B:C0030011
nicotinamide	B:C2613148
adenine	I:C2613148
dinucleotide	I:C2613148
(	I:C2613148
NAD	I:C2613148
(	I:C2613148
+	I:C2613148
)	I:C2613148
)	I:C2613148
dependent	I:C2613148
deacetylases	I:C2613148
linked	O
to	O
the	O
metabolic	O
status	O
of	O
the	O
cell	B:C0007634
.	O

SIRT	B:C2002817
4	I:C2002817
is	O
known	O
to	O
have	O
regulatory	B:C1327622
functions	I:C1327622
in	O
fatty	B:C1158366
acid	I:C1158366
oxidation	I:C1158366
.	O

The	O
HELLP	B:C0162739
syndrome	I:C0162739
is	O
often	O
associated	O
with	O
short	O
-	O
term	O
hypoxia	B:C0242184
.	O

We	O
studied	B:C2603343
sirtuins	B:C1136177
(	O
SIRT	B:C1101544
1	I:C1101544
,	O
SIRT	B:C1143857
3	I:C1143857
,	O
and	O
SIRT	B:C2002817
4	I:C2002817
)	O
in	O
human	B:C3179121
umbilical	I:C3179121
vein	I:C3179121
endothelial	I:C3179121
cells	I:C3179121
from	O
pregnancies	B:C0032962
complicated	I:C0032962
by	O
the	O
HELLP	B:C0162739
syndrome	I:C0162739
and	O
uncomplicated	O
pregnancies	B:C0032961
exposed	O
to	O
hypoxia	B:C0242184
(	O
n	O
=	O
7	O
controls	O
,	O
7	O
HELLP	B:C0162739
;	O
0	O
,	O
10	O
,	O
60	O
,	O
or	O
120	O
minutes	O
of	O
2	O
%	O
O2	B:C0030054
)	O
.	O

Protein	B:C0033684
levels	O
of	O
SIRT	B:C2002817
4	I:C2002817
were	O
significantly	O
higher	O
in	O
human	B:C3179121
umbilical	I:C3179121
vein	I:C3179121
endothelial	I:C3179121
cells	I:C3179121
from	O
HELLP	B:C0162739
compared	O
to	O
control	O
after	O
60	O
and	O
120	O
minutes	O
of	O
hypoxia	B:C0242184
.	O

The	O
NAD	B:C0027270
(	I:C0027270
+)	I:C0027270
levels	O
increased	O
in	O
a	O
time	O
-	O
dependent	O
manner	O
.	O

